TY  - JOUR
AU  - Camerini, A
AU  - Morabito, A
AU  - Montanino, A
AU  - Bernabé, R
AU  - Grossi, F
AU  - Ramlau, R
AU  - Ciuleanu, T-E
AU  - Ceresoli, G-L
AU  - Pasello, G
AU  - de Marinis, F
AU  - Bosch-Barrera, J
AU  - Laundreau, P
AU  - Gautier, S
AU  - Ta Thanh Minh, C
AU  - Kowalski, D
PY  - 2021
DO  - 10.1016/j.esmoop.2021.100051
UR  - http://hdl.handle.net/10668/17206
T2  - ESMO open
AB  - To assess the efficacy and safety of a metronomic schedule of oral vinorelbine (mVNR) in advanced non-small-cell lung cancer (NSCLC) in patients unfit for platinum-based combination chemotherapy. This was a multicenter, prospective, randomized,...
LA  - en
KW  - administration and dosage
KW  - carcinoma non-small-cell lung
KW  - frail
KW  - randomized controlled trial
KW  - vinorelbine
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Humans
KW  - Lung
KW  - Lung Neoplasms
KW  - Platinum
KW  - Prospective Studies
KW  - Quality of Life
KW  - Vinorelbine
TI  - Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial.
TY  - research article
VL  - 6
ER  -